EUVIMEDEUVIMED entdecken
Crossref

Lignin-Based Therapeutics: Targeting Mitochondrial Pathways in Osteosarcoma

Yilin Wang, Sheng Zhou iD, Zaikai Zhuang, Xueying An iD, Wenjuan Wu iD, Bo Jiang iD, Chaofeng Zhang iD, Sehrish Manan, Peng Wang, Yongcan Jin iD

Journal of Agricultural and Food Chemistry · 2025

DOI: 10.1021/acs.jafc.5c01065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Agricultural and Food Chemistry, 2025. Verfasst von Yilin Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, International Innovation Center for Forest Chemicals and Ma…. Hauptthemen laut MEDLINE: Osteosarcoma, Lignin, Mitochondria, Antineoplastic Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: Graduate Research and Innovation Projects of Jiangsu Province, Natural Science Foundation of Jiangsu Province, Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lignin is a natural product that holds significant potential in tumor treatment by inhibiting tumor growth and inducing apoptosis. However, its therapeutic efficacy is often constrained by challenges such as inconsistent bioavailability, structural complexity, and potential side effects. To address these challenges, we developed a series of lignin derivatives incorporating bioactive intermediate structures to enhance their antitumor activity. These derivatives efficiently induced apoptosis in osteosarcoma (OS) through a mitochondria-dependent pathway. Notably, lignin derivatives with amino groups demonstrated pronounced cytotoxicity, while those featuring benzylamine substituents exhibited strong therapeutic effects, achieving tumor inhibition rates of up to 48%. Mechanistic investigations revealed that these derivatives disrupt mitochondrial membrane permeability, leading to cytochrome C release and subsequent activation of the apoptotic cascade. This process was characterized by the upregulation of BAX, Cyto-c, cleaved CASP3, and CASP9 and downregulation of BCL2. Both in vitro and in vivo experiments confirmed that lignin derivatives significantly inhibited OS cell proliferation while maintaining a favorable biosafety profile. These results demonstrate the therapeutic potential of lignin derivatives in OS treatment by leveraging renewable resources to synthesize bioactive intermediates. This innovative approach not only enhances therapeutic efficacy but also establishes a sustainable paradigm for pharmaceutical development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaLigninMitochondriaAntineoplastic AgentsBone NeoplasmsHumansAnimalsApoptosisCell Line, TumorCell ProliferationMiceCaspase 3Femalebcl-2-Associated X ProteinProto-Oncogene Proteins c-bcl-2Caspase 9

Stichwörter der Autor:innen

antitumor activityapoptosisfunctionalized ligninmitochondria-dependent pathwaymitochondrial damageosteosarcoma treatment

Substanzen

LigninAntineoplastic AgentsCaspase 3bcl-2-Associated X ProteinProto-Oncogene Proteins c-bcl-2Caspase 9

Autor:innen und Institutionen

  • Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, International Innovation Center for Forest Chemicals and Materials, Nanjing Forestry University, Nanjing 210037, China.
  • State Key Laboratory of Pharmaceutical Biotechnology, Department of Sports Medicine and Adult Reconstructive Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing 21…

ORCID-Profile: Sheng Zhou, Xueying An, Wenjuan Wu, Bo Jiang, Chaofeng Zhang, Yongcan Jin

Förderung

  • Graduate Research and Innovation Projects of Jiangsu Province
  • Natural Science Foundation of Jiangsu Province
  • Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau
  • National Natural Science Foundation of China

Zitieren

APA

Wang, Y., Zhou, S., Zhuang, Z., An, X., Wu, W., Jiang, B., Zhang, C., Manan, S., Wang, P., & Jin, Y. (2025). Lignin-Based Therapeutics: Targeting Mitochondrial Pathways in Osteosarcoma. Journal of Agricultural and Food Chemistry. https://doi.org/10.1021/acs.jafc.5c01065

Vancouver

Wang Y, Zhou S, Zhuang Z, An X, Wu W, Jiang B, et al. Lignin-Based Therapeutics: Targeting Mitochondrial Pathways in Osteosarcoma. Journal of Agricultural and Food Chemistry. 2025. doi:10.1021/acs.jafc.5c01065

BibTeX
@article{Wang2025,
  author = {Wang, Yilin and Zhou, Sheng and Zhuang, Zaikai and An, Xueying and Wu, Wenjuan and Jiang, Bo and Zhang, Chaofeng and Manan, Sehrish and Wang, Peng and Jin, Yongcan},
  title = {Lignin-Based Therapeutics: Targeting Mitochondrial Pathways in Osteosarcoma},
  journal = {Journal of Agricultural and Food Chemistry},
  year = {2025},
  doi = {10.1021/acs.jafc.5c01065}
}
Kostenlos starten →